Metoprolol 50mg tablets

Nchi: Uingereza

Lugha: Kiingereza

Chanzo: MHRA (Medicines & Healthcare Products Regulatory Agency)

Viambatanisho vya kazi:

Metoprolol tartrate

Inapatikana kutoka:

Accord-UK Ltd

ATC kanuni:

C07AB02

INN (Jina la Kimataifa):

Metoprolol tartrate

Kipimo:

50mg

Dawa fomu:

Oral tablet

Njia ya uendeshaji:

Oral

Darasa:

No Controlled Drug Status

Dawa ya aina:

Valid as a prescribable product

Bidhaa muhtasari:

BNF: 02040000; GTIN: 5060149319826

Taarifa za kipeperushi

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT
METOPROLOL TARTRATE
50 MG TABLETS
METOPROLOL TARTRATE
100 MG TABLETS
METOPROLOL TARTRATE
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU
START TAKING THIS MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
•
Keep this leaflet. You may need to read it again.
•
If you have any further questions, ask your
doctor or pharmacist.
•
This medicine has been prescribed for you only.
Do not pass it on to others. It may harm them,
even if their signs of illness are the same as
yours.
•
If you get any side effects,talk to your doctor or
pharmacist. This includes any possible side
effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET:
1. What Metoprolol Tartrate tablets are and what
they are used for
2. What you need to know before you take
Metoprolol Tartrate tablets
3. How to take Metoprolol Tartrate tablets
4. Possible side effects
5. How to store Metoprolol Tartrate tablets
6. Contents of the pack and other information 1. WHAT METOPROLOL TARTRATE
TABLETS ARE AND WHAT THEY ARE
USED FOR
Metoprolol tartrate, belongs to a group of
medicines called beta blockers.
It is used to treat:
•
high blood pressure
•
angina pectoris (pain in the chest caused by
blockages in the arteries to the heart)
•
irregular heart rhythm (arrhythmia)
•
the symptoms caused by an overactive thyroid
gland (thyrotoxicosis)
It is used to PREVENT:
•
heart damage and death due to heart attacks
•
migraine 2. WHAT YOU NEED TO KNOW BEFORE
YOU TAKE METOPROLOL TARTRATE
TABLETS
DO NOT TAKE METOPROLOL TARTRATE TABLETS if you:
•
are allergic to metoprolol, other beta-blockers
or any other ingredients of this medicine (listed
in section 6).
•
suffer with HEART CONDUCTION or RHYTHM
PROBLEMS
•
have severe or uncontrolled heart failure
•
are in shock caused by heart problems
•
suffer with BLOCKED BLOOD VESSELS, including
BLOOD CIRCULATION PROBLEMS (which may cause
your fingers and toes to tingle or turn pale or blue)
•
have a slow heart rate or have suffered a heart

Tabia za bidhaa

OBJECT 1
METOPROLOL TARTRATE 50 MG TABLETS
Summary of Product Characteristics Updated 24-Oct-2017 | Accord
Healthcare Limited
1. Name of the medicinal product
Metoprolol Tartrate 50 MG TABLETS
2. Qualitative and quantitative composition
Each tablet contains Metoprolol tartrate 50 mg
For a full list of excipients, see section 6.1.
3. Pharmaceutical form
Tablet
White to off-white, approximately 8 mm round, biconvex tablet marked
on one side and a
scoreline on the other side.
The tablet can be divided into equal halves.
4. Clinical particulars
4.1 Therapeutic indications
• Hypertension
• Angina pectoris
• Tachyarrhythmias, in particular supraventricular tachycardia
• Maintenance treatment after a myocardial infarction
• Prophylaxis of migraine
Metoprolol is indicated in adults.
4.2 Posology and method of administration
Metoprolol tartrate tablets should be administered orally.
The tablets should be taken on an empty stomach.
The dose must always be adjusted to the individual requirements of the
patient. The following are
guidelines:
Posology
_Hypertension _
The usual dose is 100mg to 200mg daily, given as a single dose in the
morning, or in divided doses
(morning and evening). Begin with 50mg twice daily or 100mg once
daily. Dose increments should be at
weekly intervals thereafter according to individual patient responses.
Maximum dose, usually 200mg
daily. If necessary, it may be taken in combination with other
antihypertensive drugs.
_Angina pectoris _
The usual dose is 100 to 200 mg daily, given in divided doses (morning
and evening). Begin with 50mg
twice daily. Dose increments should be at weekly intervals thereafter
according to individual patient
responses. Maximum dose, usually 200mg daily (in divided doses). If
necessary, it may be taken in
combination with other antianginal drugs.
_Cardiac arrhythmias _
The usual dose is 100 to 150 mg per day, in divided doses (in the
morning and in the evening). This
dosage may be increased, where necessary.
_Myocardial infarctions _
Maintenance therapy
The oral